Angioplasties performed at centers without on-site surgery services are safe, study finds

December 13, 2011

ROCHESTER, Minn. -- Contrary to current guidelines, Mayo Clinic researchers have found that elective or primary (in patients who have had heart attacks) angioplasties performed at centers without on-site cardiac surgery capabilities pose no increased risk for patient death or emergency bypass surgery. Results of the study were published in today's Journal of the American Medical Association and have implications for how care can be delivered to heart attack patients and for performance of angioplasties at centers without on-site surgery.

For the study, researchers systematically searched papers about angioplasties performed at centers with and without on-site surgery; the papers were published between 1990 and 2010 in several medical databases. Fifteen studies met the inclusion criteria and included thousands of patients. For the 124,074 patients who had primary angioplasties performed to unblock their coronary arteries in the setting of heart attack where timely treatment is crucial and lifesaving, the mortality rate was 4.6 percent for sites without on-site surgery and 7.2 percent for sites with on-site surgery.

"More than 900,000 patients had angioplasty done in an elective or urgent setting," says Mandeep Singh, M.D., Mayo Clinic cardiologist and lead author of the study. "Again, we did not find any higher risk of in-hospital death in patients who had their angioplasties performed at centers with on-site surgery compared to centers without. This study demonstrates that any type of angioplasty can be safely performed at centers that do not have on-site surgical capability."

The researchers also found that the incidence of emergency coronary artery bypass surgery for both classifications of patients was low at centers without on-site surgery capabilities. For primary angioplasty done in patients with heart attacks, the observed rate of emergency cardiac surgery was 0.22 percent at centers without on-site surgery compared to 1.03 percent at centers with on-site surgery; for all other patients, the rates of emergency heart surgery were 0.17 percent and 0.29 percent, at centers without and with on-site surgery.

Guidelines published by the American College of Cardiology and American Heart Association (ACC/AHA) recently revised their recommendations favorably toward the performance of angioplasty at centers without on-site surgery, and "our study that combines the results of a large number of more recent studies with similar outcomes of angioplasties at centers with and without on-site surgery, provides further evidence in support of safety of angioplasty procedures at centers without on-site surgical facilities," Dr. Singh says.
Other Mayo Clinic co-authors of the study are David Holmes, Jr., M.D.; Gregory Dehmer, M.D.; Ryan Lennon; Thomas Wharton, M.D.; Michael Kutcher, M.D.; Thomas Aversano, M.D.; and Charanjit Rihal, M.D.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit and

Mayo Clinic

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to